Research graph
References from A Tissue-Targeted Immunotherapy Protects Against Recurrent Ocular Herpes Infection and Disease, and Alleviates the Associated Cognitive, Behavioral, and Social Deficits in a ‘Humanized’ HLA Transgenic Mouse Model of UVB-Induced Reactivation. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1080/09286586.2021.1962919
10.1080/09286586.2021.1962919 · External reference
Herpes Simplex Virus Cell Entry Mechanisms: An Update
2020 · External reference
10.1371/journal.ppat.1007054
10.1371/journal.ppat.1007054 · External reference
10.2217/fvl.10.74
10.2217/fvl.10.74 · External reference
Sensory Nerve Retraction and Sympathetic Nerve Innervation Contribute to Immunopathology of Murine Recurrent Herpes Stromal Keratitis
10.1167/iovs.63.2.4 · 2022 · External reference
10.1016/j.tim.2020.03.003
10.1016/j.tim.2020.03.003 · External reference
10.1080/21505594.2021.1982373
10.1080/21505594.2021.1982373 · External reference
10.2217/fmb.11.73
10.2217/fmb.11.73 · External reference
Herpes simplex keratitis: A brief clinical overview
2024 · External reference
10.1016/j.bbi.2009.04.009
10.1016/j.bbi.2009.04.009 · External reference
10.3390/microorganisms10112224
10.3390/microorganisms10112224 · External reference
10.1016/b978-0-12-818731-9.00109-9
10.1016/b978-0-12-818731-9.00109-9 · External reference
Vaccine value profile for herpes simplex virus
10.1016/j.vaccine.2024.01.044 · 2024 · External reference
Developments in Vaccination for Herpes Simplex Virus
10.3389/fmicb.2021.798927 · 2021 · External reference
Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design
10.3389/fimmu.2019.00373 · 2019 · External reference
A review of HSV pathogenesis, vaccine development, and advanced applications
10.1186/s43556-024-00199-7 · 2024 · External reference
10.3390/vaccines12101181
10.3390/vaccines12101181 · External reference
Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silico
10.1038/s41598-025-92956-z · 2025 · External reference
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
10.1016/j.omtm.2023.101110 · 2023 · External reference
T cells in health and disease
10.1038/s41392-023-01471-y · 2023 · External reference
Role of T cells in cancer immunotherapy: Opportunities and challenges
10.1016/j.cpt.2022.12.002 · 2023 · External reference
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential
10.1038/s12276-023-01105-x · 2023 · External reference
10.1038/nri778
10.1038/nri778 · External reference
The fellowship of regulatory and tissue-resident memory cells
10.1038/s41385-021-00456-w · 2022 · External reference
10.3389/fimmu.2018.01574
10.3389/fimmu.2018.01574 · External reference
10.1038/nm.3883
10.1038/nm.3883 · External reference
Human mucosal tissue-resident memory T cells in health and disease
10.1038/s41385-021-00467-7 · 2022 · External reference
10.1016/j.coviro.2016.11.011
10.1016/j.coviro.2016.11.011 · External reference
10.1016/bs.ai.2018.02.002
10.1016/bs.ai.2018.02.002 · External reference
CD8+ tissue-resident memory T-cell development depends on infection-matching regulatory T-cell types
10.1038/s41467-023-41364-w · 2023 · External reference
10.1038/s41417-021-00303-x
10.1038/s41417-021-00303-x · External reference
10.1101/2024.02.03.578580
10.1101/2024.02.03.578580 · External reference
10.4049/jimmunol.0904089
10.4049/jimmunol.0904089 · External reference
Adeno-associated virus as a delivery vector for gene therapy of human diseases
10.1038/s41392-024-01780-w · 2024 · External reference
Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
10.1016/j.gendis.2023.02.010 · 2024 · External reference
10.3390/cells12050785
10.3390/cells12050785 · External reference
Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia
10.1016/j.omtm.2021.04.017 · 2021 · External reference
10.1146/annurev-med-043021-033013
10.1146/annurev-med-043021-033013 · External reference
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice
10.1038/mtm.2015.22 · 2015 · External reference
Regulation of herpes simplex virus type 1 latency-reactivation cycle and ocular disease by cellular signaling pathways
10.1016/j.exer.2022.109017 · 2022 · External reference
CXCR3-Expressing T Cells in Infections and Autoimmunity
10.31083/j.fbl2908301 · 2024 · External reference
10.3389/fimmu.2017.01970
10.3389/fimmu.2017.01970 · External reference
10.4049/jimmunol.1003735
10.4049/jimmunol.1003735 · External reference
10.4049/jimmunol.1700145
10.4049/jimmunol.1700145 · External reference
10.1128/jvi.01991-19
10.1128/jvi.01991-19 · External reference
A tissue-targeted prime/pull/keep therapeutic herpes simplex virus vaccine protects against recurrent ocular herpes infection and disease in HLA-A*0201 transgenic rabbits
10.1128/jvi.00135-25 · 2025 · External reference
10.4049/jimmunol.2000131
10.4049/jimmunol.2000131 · External reference
Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation
10.1007/s13365-015-0348-9 · 2015 · External reference
10.1128/jcm.38.7.2638-2642.2000
10.1128/jcm.38.7.2638-2642.2000 · External reference
10.1128/jvi.00692-08
10.1128/jvi.00692-08 · External reference
10.3390/ijms21186582
10.3390/ijms21186582 · External reference
Asymptomatic neonatal herpes simplex virus infection in mice leads to persistent CNS infection and long-term cognitive impairment
10.1371/journal.ppat.1012935 · 2025 · External reference
10.1007/978-1-4939-8994-2_10
10.1007/978-1-4939-8994-2_10 · External reference
10.1016/j.physbeh.2021.113652
10.1016/j.physbeh.2021.113652 · External reference
10.3791/3769
10.3791/3769 · External reference
Automated three-chambered social approach task for mice
2011 · External reference
10.1038/s41596-020-0382-9
10.1038/s41596-020-0382-9 · External reference
10.1128/jvi.07107-11
10.1128/jvi.07107-11 · External reference
Human alpha-herpesvirus 1 (HSV-1) viral replication and reactivation from latency are expedited by the glucocorticoid receptor
2025 · External reference
10.1080/21645515.2022.2048622
10.1080/21645515.2022.2048622 · External reference
10.1002/eji.200425463
10.1002/eji.200425463 · External reference
10.1172/jci2860
10.1172/jci2860 · External reference
10.1093/infdis/jiu177
10.1093/infdis/jiu177 · External reference
10.1056/nejmoa1103151
10.1056/nejmoa1103151 · External reference
10.1007/s13365-011-0067-9
10.1007/s13365-011-0067-9 · External reference
10.1007/s13365-011-0063-0
10.1007/s13365-011-0063-0 · External reference
10.3390/v16091476
10.3390/v16091476 · External reference
10.1111/j.1600-065x.2011.01074.x
10.1111/j.1600-065x.2011.01074.x · External reference
10.3390/v17050600
10.3390/v17050600 · External reference
10.1128/jvi.02745-12
10.1128/jvi.02745-12 · External reference
10.1080/21505594.2024.2425744
10.1080/21505594.2024.2425744 · External reference
Adoption of Innovation in Herpes Simplex Virus Keratitis
2020 · External reference
Tissue-resident immune cells: from defining characteristics to roles in diseases
10.1038/s41392-024-02050-5 · 2025 · External reference
10.1126/sciimmunol.aas9673
10.1126/sciimmunol.aas9673 · External reference
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
10.1038/s41467-019-12319-x · 2019 · External reference
10.3390/v13030359
10.3390/v13030359 · External reference
10.3390/v17020239
10.3390/v17020239 · External reference
10.3389/fimmu.2025.1568258
10.3389/fimmu.2025.1568258 · External reference
10.1128/jvi.01596-23
10.1128/jvi.01596-23 · External reference
Targeting cytokine and chemokine signaling pathways for cancer therapy
10.1038/s41392-024-01868-3 · 2024 · External reference
10.3389/fimmu.2020.594609
10.3389/fimmu.2020.594609 · External reference
10.1016/j.ctrv.2017.11.007
10.1016/j.ctrv.2017.11.007 · External reference
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection
10.1128/jvi.01096-23 · 2023 · External reference
CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
10.1016/j.ymthe.2022.08.021 · 2023 · External reference
10.1177/10732748241241162
10.1177/10732748241241162 · External reference
Optimal generation of hepatic tissue-resident memory CD4 T cells requires IL-1 and IL-2
10.1073/pnas.2214699120 · 2023 · External reference
10.1038/mi.2017.101
10.1038/mi.2017.101 · External reference
10.3390/cancers12123586
10.3390/cancers12123586 · External reference
10.4049/jimmunol.1301415
10.4049/jimmunol.1301415 · External reference
10.1128/jvi.00788-15
10.1128/jvi.00788-15 · External reference
The Herpes Simplex Virus LAT Gene is Associated with a Broader Repertoire of Virus-Specific Exhausted CD8+ T Cells Retained Within The Trigeminal Ganglia of Latently Infected HLA Transgenic Rabbits
2015 · External reference
10.1167/iovs.15-17074
10.1167/iovs.15-17074 · External reference
Herpes Simplex Virus Type 1 Human Asymptomatic CD8 T cell Epitopes Protect Against Ocular Herpes in “Humanized” HLA Transgenic Rabbit Model
2015 · External reference
10.1128/jvi.02450-15
10.1128/jvi.02450-15 · External reference
10.1128/jvi.02450-15
10.1128/jvi.02450-15 · External reference
10.1128/jvi.00535-18
10.1128/jvi.00535-18 · External reference
10.1128/jvi.00827-19
10.1128/jvi.00827-19 · External reference
10.3390/vaccines13090908
10.3390/vaccines13090908 · External reference
10.1084/jem.20021109
10.1084/jem.20021109 · External reference
10.1084/jem.20082039
10.1084/jem.20082039 · External reference
10.1038/nature11522
10.1038/nature11522 · External reference
Tissue-resident memory T cells populate the human brain
10.1038/s41467-018-07053-9 · 2018 · External reference
10.1073/pnas.1915681117
10.1073/pnas.1915681117 · External reference
10.1016/j.celrep.2017.08.078
10.1016/j.celrep.2017.08.078 · External reference
10.3390/cancers8030036
10.3390/cancers8030036 · External reference
10.1128/jvi.00278-17
10.1128/jvi.00278-17 · External reference
Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion
10.1038/s41392-025-02327-3 · 2026 · External reference
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
10.1126/sciimmunol.adn1945 · 2025 · External reference
10.3390/v16071037
10.3390/v16071037 · External reference
10.1093/nar/gkq1128
10.1093/nar/gkq1128 · External reference
10.5772/64447
10.5772/64447 · External reference
10.1155/2012/149135
10.1155/2012/149135 · External reference
10.4049/jimmunol.180.1.426
10.4049/jimmunol.180.1.426 · External reference
10.1128/jvi.00788-15
10.1128/jvi.00788-15 · External reference
10.4161/hv.27762
10.4161/hv.27762 · External reference
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
10.3389/fimmu.2020.00670 · 2020 · External reference
